TempraMed

Sammamish, United States

TempraMed provides last-mile control and management solutions to protect patients from temperature-sensitive medications.

$1.8M raised

Oct 2025

Post-IPO Equity

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TempraMed

How much funding has TempraMed raised?

TempraMed has raised $1.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.

Where is TempraMed headquartered?

TempraMed is headquartered in Sammamish, United States.

What does TempraMed do?

TempraMed provides last-mile control and management solutions to protect patients from temperature-sensitive medications.

What stage is TempraMed at?

TempraMed is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 21, 2025.

MLA

"TempraMed — Funding & Investors." VCBacked, October 21, 2025, https://www.vcbacked.co/company/tempramed. Accessed July 3, 2026.

APA

VCBacked. (2025). TempraMed — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tempramed

Wikipedia (cite web)

{{cite web |title=TempraMed — Funding & Investors |url=https://www.vcbacked.co/company/tempramed |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 21, 2025.